by EDTA clearance, was impaired at 53 mVmin. A renal biopsy showed changes consistent with chronic interstitial fibrosis. There were no arterial or glomerular changes suggestive of scleroderma. Electron microscopy revealed subepithelial deposits suggestive of early membranous glomerulonephritis. In view of the renal changes, the penicillamine was stopped and treatment with melphalan and cryoheptidine was given for 3 months. In November 1979, when she was off all treatment, her blood pressure was 140/90 mmHg. miminute. However, in neither of these 2 patients was there evidence of rapidly deteriorating renal function. Return of renal function has also been described in patients with renal scleroderma crisis when blood pressure control has been achieved by conventional treatment even after the patient has been on dialysis for some months4.
In the 2 patients reported on here there was evidence of activation of the renin-angiotensin systems, and in both the blood pressure was well controlled with small doses of captopril. Despite blockade of the formation of angiotensin II, renal function continued to deteriorate in the first and failed to improve in the second patient, and there was no improvement in either patient's scleroderma. Both these patients had evidence of advanced disease at the time captopril was started. There is evidence that the reninangiotensin system is activated in patients with scleroderma whose renal biopsies show vascular abnormalities but whose renal function is normal.5 '6 
